Mass Drug Administration for Lymphatic Filariasis Campaign Kicks Off to Boost Coverage in WNBP

JICA has been implementing “The Project for Elimination of Lymphatic Filariasis Phase 2” with National Department of Health (NDOH) and other partners. The first Mass Drug Administration (MDA) for Lymphatic Filariasis rollout officially began in West New Britain Province (WNBP) on 27 November 2023, to eliminate this preventable Neglected Tropical Diseases (NTD’s), also being free from the relative disease. The target population is approximately 380,000 people in WNBP (exclusion of pregnant women), which needs to cover the hard-reach areas.

JICA aligning with NDOH, WHO is supporting West New Britain Provincial Health Authority (WNBPHA) with planning, distribution for drugs and campaign items, staff training, data management for reporting, and monitoring. This campaign will end in December 2023.